Search for other papers by Leqi He in
Google Scholar
PubMed
Search for other papers by Xiaoying Li in
Google Scholar
PubMed
Search for other papers by Zaoping Chen in
Google Scholar
PubMed
Search for other papers by Wei Wang in
Google Scholar
PubMed
Search for other papers by Kai Wang in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wencai Ke in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
criteria: (i) miscarriage risk, (ii) iron deficiency, (iii) history of thyroid disease or other chronic diseases (e.g. autoimmune diseases, hypertension, cancer, and diabetes), and (iv) use of oral drugs affecting thyroid function (e.g. traditional Chinese
Search for other papers by Bliss Anderson in
Google Scholar
PubMed
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
–8% (49) (with anti-PD-1) Seen less commonly in anti-CTLA-4 therapy (8, 9) Anti-thyroid drugs only in Graves’ disease (51, 52, 53, 54, 55) 14–20% (combined therapy) (49, 50) High dose steroids if severe thyroiditis seen (49
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wencai Ke in
Google Scholar
PubMed
Search for other papers by Fanfan Pan in
Google Scholar
PubMed
Search for other papers by Xinmei Huang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
Introduction Graves' disease (GD), also known as an organ-specific autoimmune disorder, is characterized by high radioactive iodine uptake (RAIU) and hyperthyroidism ( 1 ). Excessive production of thyroid hormones results in a substantially
Search for other papers by Jiashu Li in
Google Scholar
PubMed
Search for other papers by Aihua Liu in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Haixia Liu in
Google Scholar
PubMed
Search for other papers by Chenyan Li in
Google Scholar
PubMed
Search for other papers by Weiwei Wang in
Google Scholar
PubMed
Search for other papers by Cheng Han in
Google Scholar
PubMed
Search for other papers by Xinyi Wang in
Google Scholar
PubMed
Search for other papers by Yuanyuan Zhang in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
of gestation. Gestational age was determined by last menstruation period and ultrasound of fetus. Exclusion criteria applied to multiple pregnancies, patients with thyroid disease history, diabetes, abnormal liver enzymes and any other chronic
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Catarina Tavares in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Institute of Biomedical Sciences of Abel Salazar (ICBAS), Porto, Portugal
Search for other papers by Maria João Coelho in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Catarina Eloy in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, University and Hospital Center of Coimbra, Coimbra, Portugal
Medical Faculty, University of Coimbra, Coimbra, Portugal
Search for other papers by Miguel Melo in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Public Health Unit, ACeS Baixo Mondego, Coimbra, Portugal
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Ana Pestana in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Rui Batista in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Luciana Bueno Ferreira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Hospital de S. João, Porto, Portugal
Search for other papers by Elisabete Rios in
Google Scholar
PubMed
Search for other papers by Samia Selmi-Ruby in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Institute of Biomedical Sciences of Abel Salazar (ICBAS), Porto, Portugal
Search for other papers by Bruno Cavadas in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Luísa Pereira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Hospital de S. João, Porto, Portugal
Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Medical Faculty of the University of Porto, Porto, Portugal
Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
-driven PTCs, with RAS -like PTCs having relatively high thyroid differentiation score ( 30 ). Our results on the immunohistochemical NIS expression in normal thyroid and Graves’ disease (an autoimmune condition known to express high levels of NIS) ( 42
Search for other papers by Avinaash Maharaj in
Google Scholar
PubMed
Search for other papers by Ruth Kwong in
Google Scholar
PubMed
Search for other papers by Jack Williams in
Google Scholar
PubMed
Search for other papers by Christopher Smith in
Google Scholar
PubMed
Search for other papers by Helen Storr in
Google Scholar
PubMed
Search for other papers by Ruth Krone in
Google Scholar
PubMed
Search for other papers by Debora Braslavsky in
Google Scholar
PubMed
Search for other papers by Maria Clemente in
Google Scholar
PubMed
Search for other papers by Nanik Ram in
Google Scholar
PubMed
Search for other papers by Indraneel Banerjee in
Google Scholar
PubMed
Search for other papers by Semra Çetinkaya in
Google Scholar
PubMed
Search for other papers by Federica Buonocore in
Google Scholar
PubMed
Search for other papers by Tülay Güran in
Google Scholar
PubMed
Search for other papers by John C Achermann in
Google Scholar
PubMed
Search for other papers by Louise Metherell in
Google Scholar
PubMed
Search for other papers by Rathi Prasad in
Google Scholar
PubMed
including renal disease and endocrinopathy ultimately affect growth, particularly if identified late or not adequately treated. The constellation of adrenal, gonadal and thyroid disease is described in one other non-autoimmune-inherited form of adrenal
Search for other papers by Hana Vítková in
Google Scholar
PubMed
Department of Gynaecology, Obstetrics and Neonatology, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic
Search for other papers by Kateřina Anderlová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Radovan Bílek in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Felix Votava in
Google Scholar
PubMed
Search for other papers by Tomáš Brutvan in
Google Scholar
PubMed
Search for other papers by Adéla Krausová in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Eliška Potluková in
Google Scholar
PubMed
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
concentrations were collected, and all women completed a questionnaire focusing on a personal history of thyroid diseases, autoimmune and other diseases, medication, and iodine use during pregnancy. Women with GDM were followed, and data on diabetes compensation
Search for other papers by Sílvia Santos Monteiro in
Google Scholar
PubMed
Search for other papers by Tiago Silva Santos in
Google Scholar
PubMed
Search for other papers by Ana Martins Lopes in
Google Scholar
PubMed
Search for other papers by José Carlos Oliveira in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Search for other papers by André Couto Carvalho in
Google Scholar
PubMed
.0 0.91 Postsurgical Celiac disease None None I 62 88.0 29.4 3.4 33.5 0.85 Postsurgical H. pylori infection H. pylori gastritis; ‘intestinal surgery’ PPI; CC J 52 82.0 30.6 3.1 6.0 1.61 Autoimmune
Search for other papers by Ru-Xuan Zhao in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Sha Luo in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
Introduction Graves’ orbitopathy (GO) is an autoimmune disease which frequently arises in patients suffering from Graves’ disease ( 1 , 2 ). GO, often involving both eyes, is one of the most common orbital diseases in adults ( 3 , 4 ). GO
Search for other papers by Yue-Yue Wang in
Google Scholar
PubMed
Search for other papers by Qian Wu in
Google Scholar
PubMed
Search for other papers by Lu Chen in
Google Scholar
PubMed
Search for other papers by Wen Chen in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
Search for other papers by Xiao-Quan Xu in
Google Scholar
PubMed
Search for other papers by Fei-Yun Wu in
Google Scholar
PubMed
Search for other papers by Hao Hu in
Google Scholar
PubMed
Search for other papers by Huan-Huan Chen in
Google Scholar
PubMed
Introduction Thyroid-associated ophthalmopathy (TAO) is an autoimmune and inflammatory orbital disease ( 1 ). The natural course of TAO is composed of an initial active stage and a later static stage. Systemic immunosuppressive treatment is